Precision BioSciences, Inc. (DTIL)
6.67
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
6.66
-0.01
(-0.15%)
After-Hours: 20:00
Precision BioSciences Price : 6.67 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 6.65 | 6.87 | 6.57 | 6.67 | 241367.0 |
| Sep 17, 2026 | 6.77 | 6.923 | 6.41 | 6.67 | 373895.0 |
| Sep 16, 2026 | 6.65 | 6.82 | 6.53 | 6.63 | 289233.0 |
| Sep 15, 2026 | 6.86 | 6.90 | 6.48 | 6.61 | 314614.0 |
| Sep 14, 2026 | 7.13 | 7.255 | 6.85 | 6.86 | 236350.0 |
| Sep 11, 2026 | 7.28 | 7.38 | 7.06 | 7.17 | 191404.0 |
| Sep 10, 2026 | 7.16 | 7.27 | 7.035 | 7.24 | 143428.0 |
| Sep 09, 2026 | 7.38 | 7.49 | 7.15 | 7.25 | 273503.0 |
| Sep 08, 2026 | 7.41 | 7.49 | 7.20 | 7.40 | 139956.0 |
| Sep 04, 2026 | 7.32 | 7.575 | 7.32 | 7.47 | 124285.0 |
| Sep 03, 2026 | 7.48 | 7.55 | 7.23 | 7.37 | 186995.0 |
| Sep 02, 2026 | 7.66 | 7.82 | 7.24 | 7.45 | 358922.0 |
| Sep 01, 2026 | 7.54 | 7.68 | 7.49 | 7.64 | 170934.0 |
| Aug 31, 2026 | 7.75 | 7.80 | 7.492 | 7.64 | 214810.0 |
| Aug 28, 2026 | 8.37 | 8.43 | 7.72 | 7.78 | 222527.0 |
| Aug 27, 2026 | 8.54 | 8.54 | 8.21 | 8.40 | 275051.0 |
| Aug 26, 2026 | 8.58 | 8.66 | 8.33 | 8.49 | 263208.0 |
| Aug 25, 2026 | 8.43 | 8.75 | 8.33 | 8.55 | 418190.0 |
| Aug 24, 2026 | 8.82 | 8.82 | 8.36 | 8.45 | 232783.0 |
| Aug 21, 2026 | 8.81 | 9.08 | 8.63 | 8.85 | 305180.0 |
| Aug 20, 2026 | 8.60 | 9.340 | 8.59 | 8.72 | 496263.0 |
| Aug 19, 2026 | 8.34 | 8.98 | 8.30 | 8.50 | 428436.0 |
| Aug 18, 2026 | 7.44 | 8.25 | 7.44 | 8.23 | 301631.0 |
| Aug 17, 2026 | 7.45 | 7.54 | 7.37 | 7.40 | 205578.0 |
| Aug 14, 2026 | 7.26 | 7.47 | 7.18 | 7.43 | 142105.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 385.65 |
| 4D Molecular Therapeutics, Inc. | 15.22 |
| Agenus, Inc. | 7.85 |
| Anika Therapeutics, Inc. | 20.81 |
| BioCryst Pharmaceuticals, Inc. | 8.68 |
Price Related Metrics
| PS Ratio | 3.016 |
| Price to Book Value | 3.893 |
| Earnings Yield | -42.72% |
| Market Cap | 176.31M |